Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
X
Show more
Pharmacogenic testing, namely, testing an individual's response to medications due to individual genetics; drug-gene testing for medical purposes
Class 44 – Medical & beauty services
Status timeline
- 23 Apr 2024Application filedNew Application Entered
- 6 Nov 2024Assigned to an examining attorneyAssigned To Examiner
- 20 Nov 2024Office action issuedNon-Final Action Written
- 13 Jan 2025Response to office action filedTeas Response To Office Action Received
- 3 Feb 2025Approved for publicationApproved For Pub - Principal Register
- 25 Feb 2025Published for oppositionPublished For Opposition
- 22 Apr 2025Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 16 Oct 2025Statement of use filedTeas Statement Of Use Received
- 22 Apr 2026Assigned to an examining attorneyAssigned To Examiner
- 1 Jun 2026Statement of use acceptedAllowed Principal Register - Sou Accepted
- 23 Jun 2026Registered on the Principal RegisterRegistered-Principal Register
All 28 events
| 2026-06-23 | Registered-Principal Register |
| 2026-06-23 | Notice Of Registration Confirmation Emailed |
| 2026-06-01 | Allowed Principal Register - Sou Accepted |
| 2026-06-01 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2026-05-28 | Su-Examiner's Amendment Written |
| 2026-05-28 | Examiners Amendment E-Mailed |
| 2026-05-28 | Examiner's Amendment Entered |
| 2026-05-28 | Notification Of Examiners Amendment E-Mailed |
| 2026-04-22 | Assigned To Examiner |
| 2026-04-15 | Statement Of Use Processing Complete |
| 2026-04-06 | Case Assigned To Intent To Use Paralegal |
| 2025-10-16 | Teas Statement Of Use Received |
| 2025-10-16 | Use Amendment Filed |
| 2025-04-22 | Noa Mailed - Sou Required From Applicant |
| 2025-02-25 | Published For Opposition |
| 2025-02-25 | Official Gazette Publication Confirmation E-Mailed |
| 2025-02-19 | Notification Of Notice Of Publication E-Mailed |
| 2025-02-03 | Approved For Pub - Principal Register |
| 2025-01-13 | Teas Response To Office Action Received |
| 2025-01-13 | Correspondence Received In Law Office |
| 2025-01-13 | Teas/Email Correspondence Entered |
| 2024-11-20 | Non-Final Action Written |
| 2024-11-20 | Non-Final Action E-Mailed |
| 2024-11-20 | Notification Of Non-Final Action E-Mailed |
| 2024-11-06 | Assigned To Examiner |
| 2024-10-15 | New Application Office Supplied Data Entered |
| 2024-10-15 | Notice Of Design Search Code E-Mailed |
| 2024-04-23 | New Application Entered |
Goods & services by class
Class 44 Medical & beauty services
Pharmacogenic testing, namely, testing an individual's response to medications due to individual genetics; drug-gene testing for medical purposes
First use anywhere 24 Sep 2024 · First use in commerce 24 Sep 2024
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 23 Jun 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.